Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Norma, Sberna"'
Autor:
María Teresa Rosanova, David Bes, Pedro Serrano-Aguilar, Norma Sberna, Estefania Herrera-Ramos, Roberto Luis Lede
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 6 (2019)
Background: The aim of this study was to assess whether daptomycin is safer and more efficacious than comparators for the treatment of serious infection caused by gram-positive microorganisms. Methods: Electronic databases (Medline, EMBASE, the Cochr
Externí odkaz:
https://doaj.org/article/a6f9b0cd00954757a9b24aad246f394e
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 6 (2019)
Background: Resistance to antibiotics is steadily increasing. Ceftaroline has a broad spectrum of activity against clinically relevant gram-positive strains including methicillin-resistant Staphylococcus aureus . Objectives: This systematic review wa
Externí odkaz:
https://doaj.org/article/cad43ae9b7884347be3bd3a9766e01c2
Autor:
Claudia Sarkis, Griselda Berberian, Norma Sberna, Rosa Bologna, Silvina Ruvinsky, María Teresa Rosanova
Publikováno v:
Revista chilena de infectología v.37 n.1 2020
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Resumen Introducción: Vancomicina ha sido considerada como el tratamiento de elección en especial para Staphylococcus aureus resistente a meticilina (SARM); pero su escasa penetración tisular, su toxicidad renal y el requerir monitoreo de su dosis
Autor:
Marta Dell'Orso, Natalia Riva, Graciela Calle, Paulo Cáceres Guido, Norma Sberna, Paula Schaiquevich, Mariana Gatto
Publikováno v:
Journal of the American Pharmacists Association. 60:212-215
Objective Cannabis sativa was introduced in Latin America in the 16th century. Nevertheless, many years have elapsed, and scientific progress and the medicinal use of C sativa have been restricted by the national laws of the countries in the region.
Publikováno v:
Infectious Diseases. 50:489-494
Voriconazole is a second-generation triazole. It has excellent bioavailability and broad antifungal spectrum; thus, it is an attractive option for patients at high risk of invasive fungal infections (IFIs). Comparing efficacy and safety of voriconazo
Autor:
María T, Rosanova, Norma, Sberna, Claudia, Sarkis, Silvina, Ruvinsky, Griselda, Berberian, Rosa, Bologna
Publikováno v:
Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia. 37(1)
Vancomycin has been considered the treatment of choice especially for methicillin-resistant Staphylococcus aureus (MRSA) infections; but its poor tissue penetration, renal toxicity, and requiring of dosages monitoring, raises the need for new treatme
Publikováno v:
Archivos argentinos de pediatría, Volume: 117, Issue: 3, Pages: e205-e210, Published: 01 JUN 2019
Introducción. La resistencia a los antibióticos plantea un problema de salud mundial cada vez mayor, por lo que la búsqueda de nuevos y más efectivos antibióticos es prioritaria. La ceftarolina tiene un amplio espectro de actividad contra cepas
Publikováno v:
Therapeutic Advances in Infectious Disease
Therapeutic Advances in Infectious Disease, Vol 6 (2019)
Therapeutic Advances in Infectious Disease, Vol 6 (2019)
Background: Resistance to antibiotics is steadily increasing. Ceftaroline has a broad spectrum of activity against clinically relevant gram-positive strains including methicillin-resistant Staphylococcus aureus. Objectives: This systematic review was
Autor:
Carla Voto, Sandra Gómez, Claudia Sarkis, María Teresa Rosanova, Susana Carnovale, María S Mussini, Norma Sberna, Beatriz Caracciolo, Roberto Lede
Publikováno v:
Archivos Argentinos de Pediatria. 116
There is limited information on the use of posaconazole in children. This retrospective and descriptive study was conducted to evaluate the clinical, microbiological characteristics and evolution of patients treated with posaconazole between August 2
Autor:
María T, Rosanova, Carla, Voto, María S, Mussini, Claudia, Sarkis, Sandra, Gómez, Norma, Sberna, Susana, Carnovale, Beatriz, Caracciolo, Roberto, Lede
Publikováno v:
Archivos argentinos de pediatria. 116(3)
There is limited information on the use of posaconazole in children. This retrospective and descriptive study was conducted to evaluate the clinical, microbiological characteristics and evolution of patients treated with posaconazole between August 2